• Je něco špatně v tomto záznamu ?

Performance Characteristics of a Non-Fluorescent Aerolysin-Based Paroxysmal Nocturnal Hemoglobinuria (PNH) Assay for Simultaneous Evaluation of PNH Neutrophils and PNH Monocytes by Flow Cytometry, Following Published PNH Guidelines

I. Marinov, AJ. Illingworth, M. Benko, DR. Sutherland,

. 2018 ; 94 (2) : 257-263. [pub] 20160706

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19028819

BACKGROUND: CD157 has been recently reported as a useful glycosylphosphatidylinositol (GPI)-linked marker for the detection of paroxysmal nocturnal hemoglobinuria (PNH) clones in patients with suspected paroxysmal nocturnal hemoglobinuria by flow cytometry as it targets both neutrophils and monocytes. The aim of this study is to test the feasibility of a non-fluorescent aerolysin (FLAER) approach and propose an alternative for laboratories, where FLAER is not available. METHODS: We validated a non-FLAER-based single-tube, 6-color assay targeting the GPI-linked structures CD157, CD24, and CD14. We determined its performance characteristics on 20 PNH patient samples containing a variety of clone sizes and compared results with a previously validated FLAER-based approach. RESULTS: Coefficient of variation (CV) for intra-/interassay precision analyses ranged from 0.1%/0.2% to 3.02%/7.58% for neutrophils and from 0.10%/0.3% to 5.39%/6.36% for monocytes. Coefficient of determination (r2 ) for linear regression analysis of PNH clones from 20 patients ranging from 0.06% to 99.7% was 0.99 in all cases, Wilcoxon ranks test showed no statistically significant differences (P > 0.05), Bland-Altman analysis demonstrated performance agreement with mean bias ranging from 0.06 to 0.2. CONCLUSION: Our results confirm very good performance characteristics for both intra- and interassay precision analyses, favorable correlation, and agreement between the FLAER and non-FLAER-based approaches, using the CD157 GPI marker. Our experience suggests that a rapid and cost-effective simultaneous evaluation of PNH neutrophils and monocytes by flow cytometry without using FLAER is possible in areas where FLAER may not be widely available. © 2016 International Clinical Cytometry Society.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19028819
003      
CZ-PrNML
005      
20190819122307.0
007      
ta
008      
190813s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/cyto.b.21389 $2 doi
035    __
$a (PubMed)27294344
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Marinov, Iuri $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
245    10
$a Performance Characteristics of a Non-Fluorescent Aerolysin-Based Paroxysmal Nocturnal Hemoglobinuria (PNH) Assay for Simultaneous Evaluation of PNH Neutrophils and PNH Monocytes by Flow Cytometry, Following Published PNH Guidelines / $c I. Marinov, AJ. Illingworth, M. Benko, DR. Sutherland,
520    9_
$a BACKGROUND: CD157 has been recently reported as a useful glycosylphosphatidylinositol (GPI)-linked marker for the detection of paroxysmal nocturnal hemoglobinuria (PNH) clones in patients with suspected paroxysmal nocturnal hemoglobinuria by flow cytometry as it targets both neutrophils and monocytes. The aim of this study is to test the feasibility of a non-fluorescent aerolysin (FLAER) approach and propose an alternative for laboratories, where FLAER is not available. METHODS: We validated a non-FLAER-based single-tube, 6-color assay targeting the GPI-linked structures CD157, CD24, and CD14. We determined its performance characteristics on 20 PNH patient samples containing a variety of clone sizes and compared results with a previously validated FLAER-based approach. RESULTS: Coefficient of variation (CV) for intra-/interassay precision analyses ranged from 0.1%/0.2% to 3.02%/7.58% for neutrophils and from 0.10%/0.3% to 5.39%/6.36% for monocytes. Coefficient of determination (r2 ) for linear regression analysis of PNH clones from 20 patients ranging from 0.06% to 99.7% was 0.99 in all cases, Wilcoxon ranks test showed no statistically significant differences (P > 0.05), Bland-Altman analysis demonstrated performance agreement with mean bias ranging from 0.06 to 0.2. CONCLUSION: Our results confirm very good performance characteristics for both intra- and interassay precision analyses, favorable correlation, and agreement between the FLAER and non-FLAER-based approaches, using the CD157 GPI marker. Our experience suggests that a rapid and cost-effective simultaneous evaluation of PNH neutrophils and monocytes by flow cytometry without using FLAER is possible in areas where FLAER may not be widely available. © 2016 International Clinical Cytometry Society.
650    _2
$a ADP-ribosylcyklasa $x imunologie $x metabolismus $7 D036541
650    _2
$a CD antigeny $x imunologie $x metabolismus $7 D015703
650    _2
$a bakteriální toxiny $7 D001427
650    _2
$a biologické markery $x metabolismus $7 D015415
650    _2
$a antigen CD24 $x imunologie $x metabolismus $7 D051927
650    _2
$a průtoková cytometrie $x metody $7 D005434
650    _2
$a GPI-vázané proteiny $x imunologie $x metabolismus $7 D058851
650    _2
$a paroxysmální hemoglobinurie $x imunologie $x metabolismus $7 D006457
650    _2
$a lidé $7 D006801
650    _2
$a antigeny CD14 $x imunologie $x metabolismus $7 D018950
650    _2
$a monocyty $x imunologie $x metabolismus $7 D009000
650    _2
$a neutrofily $x imunologie $x metabolismus $7 D009504
650    _2
$a cytotoxické proteiny tvořící póry $7 D052899
655    _2
$a časopisecké články $7 D016428
700    1_
$a Illingworth, Andrea J $u Dahl-Chase Diagnostic Services, Bangor, Maine.
700    1_
$a Benko, Miroslav $u Exbio Praha, Prague, Czech Republic.
700    1_
$a Sutherland, D Robert $u Department of Laboratory Medicine, Toronto General Hospital, Toronto, Ontario, Canada.
773    0_
$w MED00013936 $t Cytometry. Part B, Clinical cytometry $x 1552-4957 $g Roč. 94, č. 2 (2018), s. 257-263
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27294344 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190819122541 $b ABA008
999    __
$a ok $b bmc $g 1433968 $s 1067279
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 94 $c 2 $d 257-263 $e 20160706 $i 1552-4957 $m Cytometry. Part B, Clinical cytometry $n Cytometry B Clin Cytom $x MED00013936
LZP    __
$a Pubmed-20190813
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace